This is an observational study to assess the experience of current depot medroxyprogesterone acetate (DMPA) intramuscular (IM) clients and providers when they try Depo-subQ in Uniject and offer recommendations for the introduction of this method.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Measure the acceptability of Depo-subQ in Uniject among DMPA IM family planning clients;
Timeframe: 1 year
2) Measure the acceptability of Depo-subQ in Uniject among family planning providers (both clinic-based and CHWs);
Timeframe: 1 year
Assess family planning providers' (clinic-based and CHWs) training materials.
Timeframe: 1 year